Jeffrey W Koehler

Title: The Innovations of Jeffrey W. Koehler

Introduction

Jeffrey W. Koehler is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of antiviral research, particularly through his innovative work on peptides derived from the Rift Valley Fever Virus (RVFV). His expertise and dedication have led to advancements in therapeutic treatments for various hemorrhagic fever viruses.

Latest Patents

Koehler holds a patent for "Antiviral Rift Valley Fever Virus Peptides and Methods of Use." This invention involves synthetic short peptides based on the RVFV fusion protein. These peptides serve as broad-spectrum antivirals, providing potential prophylactic and therapeutic treatments against infections caused by hemorrhagic fever viruses, including RVFV, Ebola Virus, and Andes Virus, as well as vesicular stomatitis virus.

Career Highlights

Jeffrey W. Koehler is associated with the US Government as represented by the Secretary of the Army. His work has been instrumental in developing antiviral strategies that could significantly impact public health. His research focuses on creating effective treatments for viral infections that pose serious health risks.

Collaborations

Koehler has collaborated with esteemed colleagues such as Connie S. Schmaljohn and Robert F. Garry. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in the field of virology.

Conclusion

Jeffrey W. Koehler's contributions to antiviral research exemplify the importance of innovation in addressing global health challenges. His work on RVFV peptides showcases the potential for developing effective treatments against severe viral infections.